These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27839515)

  • 1. Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin.
    Sumsakul W; Plengsuriyakarn T; Na-Bangchang K
    BMC Pharmacol Toxicol; 2016 Nov; 17(1):50. PubMed ID: 27839515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial activity of plumbagin in vitro and in animal models.
    Sumsakul W; Plengsuriyakarn T; Chaijaroenkul W; Viyanant V; Karbwang J; Na-Bangchang K
    BMC Complement Altern Med; 2014 Jan; 14():15. PubMed ID: 24410949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibitory effects of plumbagin, the promising antimalarial candidate, on human cytochrome P450 enzymes.
    Sumsakul W; Chaijaroenkul W; Na-Bangchang K
    Asian Pac J Trop Med; 2015 Nov; 8(11):914-918. PubMed ID: 26614990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the inhibition potential of plumbagin against cytochrome P450 using LC-MS/MS and cocktail approach.
    Chen A; Zhou X; Tang S; Liu M; Wang X
    Sci Rep; 2016 Jun; 6():28482. PubMed ID: 27329697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plumbagin and
    Chatuphonprasert W; Sukkasem N; Ellinger I; Jarukamjorn K
    Pak J Biol Sci; 2021 Jan; 24(11):1195-1201. PubMed ID: 34842392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay.
    Tang S; Chen A; Zhou X; Zeng L; Liu M; Wang X
    Toxicol Lett; 2017 Nov; 281():74-83. PubMed ID: 28941798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor alpha agonist in preclinical species and human.
    Frederick KS; Maurer TS; Kalgutkar AS; Royer LJ; Francone OL; Winter SM; Terra SG; Chen D; Gao X
    Xenobiotica; 2009 Oct; 39(10):766-81. PubMed ID: 19622022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic effect of plumbagin isolated from Plumbago zeylanica L. root and its effect on GLUT4 translocation in streptozotocin-induced diabetic rats.
    Sunil C; Duraipandiyan V; Agastian P; Ignacimuthu S
    Food Chem Toxicol; 2012 Dec; 50(12):4356-63. PubMed ID: 22960630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes.
    Naraharisetti SB; Aggarwal M; Sarkar SN; Malik JK
    Arch Toxicol; 2008 Aug; 82(8):543-51. PubMed ID: 18528686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of plumbagin loaded long circulating pegylated liposomes: in vivo evaluation in C57BL/6J mice bearing B16F1 melanoma.
    Kumar MR; Aithal BK; Udupa N; Reddy MS; Raakesh V; Murthy RS; Raju DP; Rao BS
    Drug Deliv; 2011; 18(7):511-22. PubMed ID: 21793763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crucial role of cytochrome P450 in hepatotoxicity induced by 2,3-dimethoxy-1,4-naphthoquinone in rats.
    Ishihara Y; Ishii S; Sakai Y; Yamamura N; Onishi Y; Shimamoto N
    J Appl Toxicol; 2011 Mar; 31(2):173-8. PubMed ID: 20803752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety assessment of Gyejibokryeong-hwan water extract: Study of acute and subacute toxicity, and influence on drug metabolizing enzymes.
    Jeon WY; Jin SE; Seo CS; Lee MY; Shin HK; Han SC; Ha H
    J Ethnopharmacol; 2019 Aug; 240():111913. PubMed ID: 31091465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR.
    de Vries EM; Lammers LA; Achterbergh R; Klümpen HJ; Mathot RA; Boelen A; Romijn JA
    PLoS One; 2016; 11(7):e0159552. PubMed ID: 27434302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver.
    Sun G; Thai SF; Tully DB; Lambert GR; Goetz AK; Wolf DC; Dix DJ; Nesnow S
    Toxicol Lett; 2005 Feb; 155(2):277-87. PubMed ID: 15603923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tetrahydrocurcumin on the profiles of drug-metabolizing enzymes induced by a high fat and high fructose diet in mice.
    Jearapong N; Chatuphonprasert W; Jarukamjorn K
    Chem Biol Interact; 2015 Sep; 239():67-75. PubMed ID: 26102010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of SPECT/CT imaging system and radiochemical analysis for investigation of blood kinetics and tissue distribution of radiolabeled plumbagin in healthy and Plasmodium berghei-infected mice.
    Sumsakul W; Karbwang J; Na-Bangchang K
    Exp Parasitol; 2016 Feb; 161():54-61. PubMed ID: 26713669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atractylodes lancea for cholangiocarcinoma: Modulatory effects on CYP1A2 and CYP3A1 and pharmacokinetics in rats and biodistribution in mice.
    Muhamad N; Plengsuriyakarn T; Na-Bangchang K
    PLoS One; 2022; 17(11):e0277614. PubMed ID: 36374864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
    Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
    Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.